반응형
| 구분 | 보고서(영문) | 업로드 날짜 |
| 제약·바이오 &임상시험 |
Thematic Research: Drug Development Scorecard, Q2 2022 Update | 06-30-2022 |
| Thematic Research: Clinical Trials Scorecard, Q2 2022 Update | 06-30-2022 | |
| Emerging Market Outsourcing Report–Q2 2022 | 06-30-2022 | |
| Bio/Pharmaceutical Outsourcing Report, June 2022 | 06-30-2022 | |
| Delayed EMA Approval: Improved Patient Safety or Lack of Access to Effective Therapeutics? | 06-17-2022 | |
| Eli Lilly Tops All Sponsors for Men’s Health Clinical Trials, but a Hospital Has Most Ongoing Trials | 06-17-2022 | |
| Bi-Monthly Disruptor Roundup: HealthTech - May 2022 | 06-17-2022 | |
| Non-Stop Investment From CMOs and US Government Into Continuous Manufacturing | 06-23-2022 | |
| Bursting Biotech Bubble: Venture Capitals Rethink Private Companies in Q1 2022 | 06-10-2022 | |
| Bear Market Hits Europe’s Innovator Drug Venture Financing, Losing Pace with US | 06-14-2022 | |
| It Will Take Years for AI Use to Peak in Pharmaceutical Drug Discovery and Development Process | 06-13-2022 | |
| Pharma Pricing, Market Access & ESG | 06-17-2022 | |
| 질환별 | China Dominates Ongoing/Planned Trials Researching Cervical Cancer | 06-21-2022 |
| Could Monkeypox Become Established Outside of Africa? | 06-21-2022 | |
| 코로나-19 | Coronavirus Disease (COVID-19) Pharma Executive Briefing–June 28, 2022 | 06-28-2022 |
| Paxlovid, the Top-Selling COVID-19 Cure | 06-23-2022 | |
| Targeting the Microbiome to Treat Infectious Diseases Is a Rapidly Emerging Field with a Largely Untapped Market | 06-15-2022 |

반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
|---|---|
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.15(금) (0) | 2023.10.06 |